MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

Two decades ago, when two genetic mutations were discovered in Asia that gave scientists a better idea of how pain sensations ...

In today’s 2024 modern era, many people are experiencing constant foot discomfort and pain. Whether it is because of ...

Research shows neuropathy can be more severe and more common in Black breast cancer patients, causing doctors to dial back ...

Dr Shiva Kumar R, head of the department and senior consultant in Neurology and Epileptology at Manipal Hospitals, Sarajapur ...

The Forbes Advisor editorial staff evaluated the most popular debt relief companies to help you make an informed decision. Our debt experts have compared 25 companies that offer debt settlement ...

Inhibiting a protein isoform in the spinal cord alongside morphine improves the opioid’s pain-relieving properties without ...

Neuropathy is becoming a bigger problem for more people than ever before. If you`re suffering from stabbing pain, numbness, ...

EXCLUSIVE: The former Coronation Street star has recruited help for her new role away from soap life, in fear of not being ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is excited to ...